Welcome to our dedicated page for Limitless X news (Ticker: LIMX), a resource for investors and traders seeking the latest updates and insights on Limitless X stock.
Limitless X Holdings Inc. reports developments across a diversified wellness, sports, entertainment, lifestyle and digital commerce business. Company news includes consumer health and performance products, e-commerce platform expansion, marketplace distribution, brand partnerships tied to boxing and athlete marketing, and entertainment production roles.
Updates also cover operational and financial highlights, capital-structure actions, governance appointments, manufacturing and supply-chain priorities, and technology-driven wellness initiatives such as BodyCor, which is described as integrating health diagnostics, artificial intelligence and consumer brands.
Limitless X Holdings (OTCQX: LIMX) announced significant strategic transformations and milestones in a comprehensive shareholder letter. The company has achieved SEC qualification for its Regulation A Tier 2 offering, introducing a new preferred stock (LIMXP) with a 15% annual dividend. Key developments include bringing all operations in-house, debt reduction initiatives, and expansion of their "Look Good, Feel Great" ecosystem.
The company is evolving beyond dietary supplements through multiple divisions: BodyCor for healthcare initiatives, Limitless Films for entertainment and marketing, and Limitless Digital Assets for blockchain and AI integration. The company's flagship products include NZT-48 supplements and is actively pursuing retail distribution expansion.
CEO Jas Mathur has agreed to relinquish debt claims related to Series C Preferred Stock to strengthen the balance sheet. The company has engaged Wilson-Davis & Co./Atlas Clear as broker-dealer for their Reg A offering.
Limitless X Holdings (OTCQB: LIMX) has received SEC qualification for its Regulation A+ offering of Series D 15% Cumulative Redeemable Perpetual Preferred Stock. The company aims to raise up to $75 million through this offering, with shares priced at $25.00 each.
The preferred stock offers a 15% annual dividend paid quarterly, targeting both retail and institutional investors. Proceeds will support operational scaling, product development, sales growth, and market expansion across the company's diverse portfolio in health, wellness, entertainment, fintech, and real estate sectors.
Limitless X Holdings (OTCQB: LIMX), a health and wellness company, highlighted its brand momentum following boxing legend Manny Pacquiao's Pay-Per-View return at MGM Grand Garden Arena. Despite a draw against WBC Welterweight Champion Mario Barrios, the event enhanced LIMX's global visibility.
The company teased an upcoming strategic initiative involving Pacquiao and CEO Jas Mathur, based on their shared values of discipline, faith, and personal transformation. Additionally, LIMX announced the launch of HealthMD Inc., a new wholly-owned subsidiary focusing on personalized medicine and preventative care, which will integrate advanced health technologies with the company's existing consumer brands.
Limitless X Holdings (OTCQB: LIMX) has secured a $250,000 bridge financing through a related-party transaction with Chairman and CEO Jas Mathur via EM1 Capital LLC. The financing is structured as a 12-month promissory note and includes an equity incentive package with restricted equity and performance-aligned warrants.
The capital will support core operations, regulatory compliance, corporate initiatives, and the launch of offline sales channels. Additionally, it will fund the early-phase development of HealthMD.com, a new subsidiary focused on the Company's wellness strategy. The investment demonstrates strong insider confidence in Limitless X's position within the $5 trillion global wellness market.
Limitless X Holdings (OTCQB: LIMX) has announced the formation of HealthMD Inc., a wholly-owned subsidiary focused on health and wellness innovation. This strategic expansion aims to complement LIMX's existing direct-to-consumer supplement business with AI-integrated technologies and holistic lifestyle solutions.
The initiative targets the $5.6 trillion global wellness market, with the U.S. market projected to exceed $2.4 trillion by 2027. HealthMD will operate at the intersection of wellness, AI healthcare (expected to reach $187 billion by 2030), and health technology (growing at 19.8% CAGR). The subsidiary is expected to drive revenue growth, achieve higher margins, and increase customer lifetime value through integrated wellness solutions.
Limitless X Holdings (OTC: LIMX) has secured a $100,000 bridge loan from EM1 Capital, LLC, an entity owned by Chairman and CEO Jas Mathur. The funding aims to support key operating expenses and strategic initiatives, including legal, audit, and compliance infrastructure.
As part of the transaction, the company issued 20,000 restricted common shares to EM1 Capital under Rule 144. The strategic funding demonstrates leadership's commitment while avoiding toxic financing structures, focusing on preserving long-term shareholder value during a crucial growth phase.
Limitless X Holdings (OTCQB: LIMX) has announced its strategic entry into the $500 billion global coffee and $2.5 trillion CPG markets with the launch of Limitless Nootropic Blend Coffee Concentrate. The product combines premium Arabica coffee with a nootropic blend featuring ingredients like Noopept, L-Theanine, and Maca Root Extract.
The concentrate is available in three flavors (Original, French Vanilla, and Mocha), priced at $29.95 for a 30-serving bottle. Each serving contains 200mg of caffeine and a 1,360mg functional blend designed to enhance cognitive performance, provide clean energy, and support mood. The product is sugar-free, vegan-friendly, and targets retail distribution through major chains and e-commerce platforms.
Limitless X Holdings (OTCQB: LIMX) announced that Chairman and CEO Jas Mathur has converted over $6.5 million in personal debt into equity through Class D Preferred Stock. The conversion includes:
- Jaspreet Mathur: $6,089,589 converted to 243,583 shares
- EM1 Capital : $262,600 converted to 10,504 shares
- Emblaze One Inc: $153,179 converted to 6,127 shares
The conversion was executed on April 14, 2025, at $25 per share. The Class D Preferred Stock includes dividend rights but is not immediately tradeable. This strategic move eliminates legacy liabilities and strengthens the company's balance sheet ahead of its planned Regulation A+ Tier 2 offering and uplisting efforts.
Limitless X Holdings (OTCQB: LIMX) has secured a $500,000 strategic financing from its Chairman and CEO, Jas Mathur, to support operational initiatives and growth. The loan features a 12.5% interest rate, maturing in six months or upon closing of a $1 million qualified financing, resulting in a total repayment of $562,500.
As part of the agreement, Limitless X will issue 225,000 restricted common shares and 10,000 Class D Perpetual Preferred Stock to Mathur. The funds will be allocated towards working capital and operational expenses, including inventory procurement, marketing initiatives, employee compensation, and legal and accounting fees.
Limitless X Holdings (OTCQB: LIMX) and its subsidiary Limitless Films have secured Executive Producer credits for the new thriller film 'High Rollers', featuring John Travolta, Gina Gershon, and Quavo. The film, which premiered on Amazon Prime on March 14th, 2025, has already reached #3 on the platform.
The movie follows a professional gambler (Travolta) who becomes entangled in a life-or-death conflict during a dangerous game. This marks the company's entry into the entertainment industry, with CEO Jas Mathur announcing plans for future collaborations with top-tier Hollywood talent through their newly launched entertainment division.